تغريدة مثبتة

We’re thrilled to announce our new exclusive option-license agreement with UgeneX Therapeutics for UGX-202, a novel, investigational #GeneTherapy designed to potentially restore vision in people living with #RetinitisPigmentosa and other retinal diseases. tinyurl.com/33v2jpyj

English










